8.53
-0.54(-5.95%)
Currency In USD
| Previous Close | 9.07 |
| Open | 9 |
| Day High | 9 |
| Day Low | 8.44 |
| 52-Week High | 54.95 |
| 52-Week Low | 5.01 |
| Volume | 21,892 |
| Average Volume | 287,955 |
| Market Cap | 5.02M |
| PE | -0.25 |
| EPS | -34.62 |
| Moving Average 50 Days | 7.54 |
| Moving Average 200 Days | 16.38 |
| Change | -0.54 |
If you invested $1000 in Quoin Pharmaceuticals, Ltd. (QNRX) since IPO date, it would be worth $0.54 as of June 01, 2025 at a share price of $8.53. Whereas If you bought $1000 worth of Quoin Pharmaceuticals, Ltd. (QNRX) shares 5 years ago, it would be worth $4.62 as of June 01, 2025 at a share price of $8.53.
For more details, use our stock calculator to calculate how much you would've made investing different amounts on specific dates.
Quoin Pharmaceuticals Announces FDA Clearance to Initiate Second Pivotal Whole Body QRX003 Netherton Syndrome Clinical Study
GlobeNewswire Inc.
May 22, 2025 11:30 AM GMT
Study CL-QRX003-002 will test whole-body application of QRX003 in conjunction with off-label systemic therapy in approximately 12-15 subjects.Study CL-QRX003-002 complements first whole-body pivotal study, CL-QRX003-003, being led by Dr. Amy Paller a
Quoin Pharmaceuticals Announces European Medicines Agency (EMA) Grants Orphan Drug Designation for QRX003 for the Treatment of Netherton Syndrome
GlobeNewswire Inc.
May 20, 2025 11:30 AM GMT
Company continues to advance QRX003 in late-stage clinical trials in Netherton Syndrome patients Regulatory milestone provides 10 years of market exclusivity in Europe upon approval ASHBURN, Va., May 20, 2025 (GLOBE NEWSWIRE) -- Quoin Pharmaceutica
Quoin Pharmaceuticals Announces Initial Positive Clinical Data for QRX003 from Pediatric Peeling Skin Syndrome Study
GlobeNewswire Inc.
May 14, 2025 11:30 AM GMT
Clear Improvement in Patient’s Skin Appearance Observed in Study after 12 weeks Compared to BaselineKey endpoints including Investigator’s Global Assessment (IGA), Modified Ichthyosis Area Severity (M-IASI) and Children’s Dermatology Life Quality Ind